Emergent BioSolutions Inc.EBS

Emergent BioSolutions Inc. (EBS): trades by Congress and the executive branch

Every trade in Emergent BioSolutions Inc. that a representative, a senator, the President or a senior official disclosed since 2019, newest report first. Each is read from the filer’s periodic transaction report and linked to it.

Latest report Jan 10, 2025 · Source · RSS feed

Trades disclosed
13since 2019
Members
3
Purchases / sales
7 / 6
Typical days to public
24median
Public after 45 days
0of 13 dated trades by Congress

Congress trade alerts · EBS · free

Get an email when anyone in Congress trades Emergent BioSolutions Inc.

Each new disclosure of a trade in the stock by a representative, a senator, the President or a senior official, with the filing.

An email when a member of Congress or the executive branch files a trade in EBS, with the filing. Unsubscribe in one click.

Transactions

Every EBS trade disclosed since 2019, newest report first
MemberAssetTypeAmountTrade dateLagPublicFiling
Steve CohenD-TNTN09EBSEmergent BioSolutions Inc.Sell$1K–$15KDec 11, 202430dJan 10PDF
Josh GottheimerD-NJNJ05EBSEmergent BioSolutions Inc. · JointSell$1K–$15KNov 5, 202138dDec 13PDF
Josh GottheimerD-NJNJ05EBSEmergent BioSolutions Inc. · JointBuy$1K–$15KOct 18, 202128dNov 15PDF
Josh GottheimerD-NJNJ05EBSEmergent BioSolutions Inc. · JointSell$1K–$15KSep 15, 202128dOct 13PDF
Josh GottheimerD-NJNJ05EBSEmergent BioSolutions Inc. · JointSell$1K–$15KFeb 23, 202115dMar 10PDF
Gilbert CisnerosD-CACA39EBSEmergent BioSolutions Inc.Buy$1K–$15KNov 24, 202021dDec 15PDF
Gilbert CisnerosD-CACA39EBSEmergent BioSolutions Inc.Buy$1K–$15KJul 30, 202020dAug 19PDF
Gilbert CisnerosD-CACA39EBSEmergent BioSolutions Inc.Buy$1K–$15KJun 30, 202017dJul 17PDF
Gilbert CisnerosD-CACA39EBSEmergent BioSolutions Inc.Buy$1K–$15KJun 19, 202028dJul 17PDF
Josh GottheimerD-NJNJ05EBSEmergent BioSolutions Inc. · JointBuy$1K–$15KJun 26, 202013dJul 9PDF
Josh GottheimerD-NJNJ05EBSEmergent BioSolutions Inc. · JointBuy$1K–$15KJun 15, 202024dJul 9PDF
Steve CohenD-TNTN09EBSEmergent BioSolutions Inc.Sell$1K–$15KMar 26, 202027dApr 22PDF
Steve CohenD-TNTN09EBSEmergent BioSolutions Inc.Sell$15K–$50KAug 29, 201914dSep 12PDF

Members who traded EBS

MemberTradesBuysSellsLast tradedLatest report
Josh GottheimerD-NJNJ05633Nov 5, 2021Dec 13, 2021
Gilbert CisnerosD-CACA39440Nov 24, 2020Dec 15, 2020
Steve CohenD-TNTN09303Dec 11, 2024Jan 10, 2025

Source

Each trade is a line of a periodic transaction report filed under the STOCK Act, read from the report itself and linked to it. Three offices publish them, and all three are read here every hour: the House Clerk for representatives, the Senate Office of Public Records for senators, and the Office of Government Ethics for the President, the Vice President and Senate-confirmed officials (OGE Form 278-T). OGE links some officials’ reports and releases the rest on request; only linked reports are here.

The Act requires a report within 45 days of the trade; the lag counts the days from the trade to the day the report became public. Reports give each amount as a range. Amendments are marked and not counted as late; trades a later report withdrew are left out. The President’s reports and some House reports are scans of paper forms: a scanned value that does not read with certainty is shown as not read, never guessed, and the report is one click away. “Since” is the stock’s move from the trade date’s close to the latest daily close.

The same trades are in the OptimistFi MCP server’s get_congress_trades tool, by filer or by stock, for each chamber: connect it. Every House trade is free to download as CSV or JSON, and every trade here can be followed by RSS: the data.

ScoutJUST THIS STORY

LET’S MAKE THIS USEFUL · 1 OF 5

How would you like me to explain this?

Tell me what you want from this read. Start with a quick note, then adjust the details. Your other stories stay as they are.

We’ll remember your view of this story. The published article stays unchanged.

THIS STORY’S READING VIEWStandard · The whole picture

Clear explanations with context. Both sides of the evidence.